abagovomab 26
abciximab 23
abituzumab 18
abrilumab 12
actoxumab 14
adalimumab 14
aducanumab 9
afasevikumab 15
alacizumab_pegol 11
alemtuzumab 21
alirocumab 16
amatuximab 32
andecaliximab 20
anifrolumab 19
anrukinzumab 15
aprutumab 12
aprutumab_ixadotin 12
arcitumomab 16
ascrinvacumab 5
atezolizumab 13
atinumab 12
avelumab 9
basiliximab 21
bavituximab 29
begelomab 22
benralizumab 20
bevacizumab_beta 15
bezlotoxumab 14
bimagrumab 8
bleselumab 9
blinatumomab 31
blosozumab 23
bococizumab 15
brazikumab 10
brentuximab_vedotin 18
briakinumab 15
brodalumab 6
brolucizumab 22
brontictuzumab 17
burosumab 13
cabiralizumab 16
camrelizumab 12
canakinumab 23
cantuzumab_ravtansin 35
carlumab 12
carotuximab 20
cergutuzumab_amunaleukin2 20
cergutuzumab_amunaleukin 20
certolizumab_pegol 18
cetiximab 31
citatuzumab_bogatox 23
cixutumumab 20
clivatuzumab_tetraxetan 13
codrituzumab 19
conatumumab 5
concizumab 25
crenezumab 11
crizanlizumab 18
crotedumab 15
dacetuzumab 17
daclizumab 10
dalotuzumab 25
dapirolizumab_pegol 21
daratumumab 13
dectrekumab 9
demcizumab 17
denosumab 10
depatuxizumab 16
depatuxizumab_mafodotin 16
dezamizumab 14
dinutuximab 32
diridavumab 13
domagrozumab 14
drozitumab 11
duligotuzumab 18
durvalumab 9
dusigitumab 8
efalizumab 26
efungumab 24
eldelumab 11
elezanumab 8
elgemtumab 8
elotuzumab 15
emactuzumab 16
emapalumab 19
emibetuzumab 10
enavatuzumab 22
enfortumab_vedotin 9
enoblituzumab 15
enokizumab 18
enoticumab 14
ensituximab 27
eptinezumab 17
erenumab 9
etaracizumab 17
etrolizumab 16
evinacumab 17
evolocumab 4
farletuzumab 12
fasinumab 18
fezakinumab 11
fibatuzumab 5
ficlatuzumab 13
firivumab 27
flanvotumab 12
fletikumab 15
foralumab 8
foravirumab 9
fremanezumab 24
fresolimumab 16
fulranumab 14
futuximab 17
galcanezumab 13
ganitumab 18
gantenerumab 10
gemetuzumab 19
gemtuzumab2 18
gemtuzumab 21
gevokizumab 18
girentuximab 20
glembatumumab 9
glembatumumab_vedotin 9
guselkumab 19
ibalizumab 20
ibritumomab 19
icrucumab 6
idarucizumab 19
ifabotuzumab 5
imalumab 14
imgatuzumab 12
inclacumab 8
indatuximab_ravtansin 27
indusatumab 11
inebilizumab 25
intetumumab 7
iodine_girentuximab 24
ipilimumab 3
iratumumab 9
isatuximab 27
itolizumab 22
ixekizumab 22
labetuzumab_govitecan 19
lambrolizumab 23
lampalizumab 20
lanadelumab 15
landogrozumab 16
laprituximab 19
lebrikizumab 30
lendalizumab 17
lenzilumab 10
lifastuzumab_vedotin 20
ligelizumab 21
lilotomab 29
lirilumab 12
lodelcizumab 10
lokivetmab 21
lorvotuzumab_mertansin 13
lucatumumab 20
lumretuzumab 11
lupartumab 7
lutikizumab 18
margetuximab 28
milatuzumab 27
mirvetuximab 26
mirvetuximab_soravtansin 26
modotuximab 27
mogamulizumab 22
monalizumab 15
motavizumab 25
moxetumomab_pasudotox 24
namilumab 8
naratuximab 20
naratuximab_emtansin 20
narnatumab 12
navicixizumab2 23
navicixizumab 18
navivumab 29
necitumumab 6
nemolizumab 19
nesvacumab 12
nivolumab 10
obiltoxaximab 16
obinutuzumab 23
ocaratuzumab 24
ofatumumab 12
olaratumab 11
olokizumab 20
omalizumab 16
onartuzumab 16
ontuxizumab 15
opicinumab 13
orticumab 9
otelixizumab 31
oxelumab 9
ozanezumab 20
pamrevlumab 6
panobacumab 11
parsatuzumab 18
pasotuxizumab 19
pateclizumab 12
patritumab 14
pembrolizumab 23
perakizumab 15
pidilizumab 18
pinatuzumab_vedotin 10
plozalizumab 23
pogalizumab 19
polatuzumab_vedotin 16
ponezumab 27
prezalumab 12
pritoxaximab 22
quilizumab 17
racotumomab 19
radretumab 13
ralpancizumab 18
ramucirumab 13
ranevetmab 17
ranibizumab 19
refanezumab 19
remtolumab 12
rilotumumab 11
rinucumab 15
risankizumab 29
rituximab 17
rivabazumab 12
robatumumab 18
roledumab 22
romosozumab 17
rontalizumab 17
rosmantuzumab 12
rozanolixizumab 13
sacituzumab 20
sacituzumab_govitecan 20
samalizumab 18
sapelizumab 20
sarilumab 9
secukinumab 9
seribantumab 12
setoxaximab 35
sifalimumab 7
siltuximab 20
simtuzumab 19
sirukumab 7
solanezumab 18
solitomab 16
stamulumab 13
suptavumab 13
suvizumab 15
tabalumab 9
tadocizumab 11
tamtuvetmab 25
tanezumab 20
tarextumab 8
tavolixizumab 14
telisotuzumab 24
teplizumab 14
tesidolumab 14
tezepelumab 18
tigatuzumab 15
tildrakizumab 18
timolumab 9
tisotumab 9
tosatoxumab 28
tositumomab 19
tralokinumab 16
trastuzumab 19
tregalizumab 21
trevogrumab 12
ublituximab 24
urelumab 15
ustekinumab 21
utomilumab 22
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 9
vantictumab 16
vanucizumab2 15
vanucizumab 19
varlilumab 10
vatelizumab 17
vedolizumab 18
veltuzumab 10
vesencumab 10
vorsetuzumab 14
vorsetuzumab_mafodotin 14
vunakizumab 25
xentuzumab 15
zatuximab 27
